• Generated on:
    This page was generated by TSDR on 2026-11-15 14:07:52 EST
    Mark:
    ZENMOUNTO
    Trademark image
    US Serial Number:
    98515531
    Application Filing Date:
    Apr. 23, 2024
    Register:
    Principal
    Mark Type:
    Trademark
    TM5 Common Status Descriptor:
    TM5 Common Status image

    LIVE/APPLICATION/Under Examination

    The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.

    Status:
    A fourth request for extension of time to file a Statement of Use has been granted.
    Status Date:
    Oct. 06, 2026
    Publication Date:
    Sep. 17, 2024
    Notice of Allowance Date:
    Nov. 12, 2024
     

    Mark Information

    Mark Literal Elements:
    ZENMOUNTO
    Standard Character Claim:
    Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
    Mark Drawing Type:
    4 - STANDARD CHARACTER MARK

    Goods and Services

    Note: The following symbols indicate that the registrant/owner has amended the goods/services:
    • Brackets [..] indicate deleted goods/services;
    • Double parenthesis ((..)) identify any goods/services not claimed in a Section 15 affidavit of incontestability; and
    • Asterisks *..* identify additional (new) wording in the goods/services.
    For:
    Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
    International Class(es):
    005 - Primary Class
    U.S Class(es):
    005, 006, 018, 044, 046, 051, 052
    Class Status:
    ACTIVE

    Basis Information (Case Level)

    Filed Use:
    No
    Currently Use:
    No
    Filed ITU:
    Yes
    Currently ITU:
    Yes
    Filed 44D:
    No
    Currently 44D:
    No
    Filed 44E:
    No
    Currently 44E:
    No
    Filed 66A:
    No
    Currently 66A:
    No
    Filed No Basis:
    No
    Currently No Basis:
    No

    Current Owner(s) Information

    Owner Name:
    Eli Lilly and Company
    Owner Address:
    Lilly Corporate Center
    Indianapolis, INDIANA UNITED STATES 46285
    Legal Entity Type:
    CORPORATION
    State or Country Where Organized:
    INDIANA

    Attorney/Correspondence Information

    Attorney of Record
    Attorney Name:
    Tiffany Trunko
    Attorney Primary Email Address:
    trademarks@lilly.com
    Attorney Email Authorized:
    Yes
    Correspondent
    Correspondent Name/Address:
    Tiffany Trunko
    ELI LILLY AND COMPANY
    LILLY CORPORATE CENTER
    INDIANAPOLIS, INDIANA United States 46285
    Phone:
    332-294-0505
    Correspondent e-mail:
    trademarks@lilly.com rudolph_john@lilly.com
    Correspondent e-mail Authorized:
    Yes
    Domestic Representative - Not Found

    Prosecution History

    Date Description Proceeding Number
    Oct. 06, 2026 NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
    Oct. 06, 2026 SOU EXTENSION 4 GRANTED
    Oct. 05, 2026 SOU EXTENSION 4 FILED
    Oct. 05, 2026 SOU TEAS EXTENSION RECEIVED
    Aug. 05, 2026 NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
    Aug. 05, 2026 SOU EXTENSION 3 GRANTED
    Apr. 01, 2026 SOU EXTENSION 3 FILED
    Aug. 03, 2026 CASE ASSIGNED TO INTENT TO USE PARALEGAL 20000
    May 23, 2026 TEAS CHANGE OF CORRESPONDENCE RECEIVED
    May 23, 2026 ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
    May 23, 2026 TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
    Apr. 01, 2026 SOU TEAS EXTENSION RECEIVED
    Oct. 07, 2025 NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
    Oct. 06, 2025 SOU EXTENSION 2 GRANTED
    Oct. 06, 2025 SOU EXTENSION 2 FILED
    Oct. 06, 2025 SOU TEAS EXTENSION RECEIVED
    Apr. 23, 2025 NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
    Apr. 23, 2025 SOU EXTENSION 1 GRANTED
    Apr. 23, 2025 SOU EXTENSION 1 FILED
    Apr. 23, 2025 SOU TEAS EXTENSION RECEIVED
    Nov. 12, 2024 NOA E-MAILED - SOU REQUIRED FROM APPLICANT
    Sep. 17, 2024 OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
    Sep. 17, 2024 PUBLISHED FOR OPPOSITION
    Aug. 28, 2024 NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
    Aug. 09, 2024 APPROVED FOR PUB - PRINCIPAL REGISTER
    Aug. 06, 2024 ASSIGNED TO EXAMINER
    Apr. 23, 2024 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
    Apr. 23, 2024 NEW APPLICATION ENTERED

    TM Staff and Location Information

    TM Staff Information
    TM Attorney:
    PRIZANT, JAMES
    Law Office Assigned:
    LAW OFFICE 135
    File Location
    Current Location:
    TMO LAW OFFICE 135
    Date in Location:
    Aug. 03, 2026